1Y Annualised Return
▲55.34%
3Y Annualised Return
▲28.95%
5Y Annualised Return
▲25.21%
10Y Annualised Return
▲0.44%
Concord Drugs Stock Performance
|
|
|
Concord Drugs Company background
Founded in: 1995
Managing director: S Nagi Reddy
Concord Drugs Limited, established in 1995, is amongst the respected pharmaceutical companies in India for manufacturing of Finished Pharmaceutical Formulations like Injectables (Small Volume parenterals, Dry Syrup powder) ,Tissue BioAdhesive, tablets, capsules and ophthalmic preparations and Readytofill Pellets. The principal activity of the Company is to manufacture licensed drugs based on the formulations approved. The Company has two manufacturing facilities license issued by The Government of Andhra Pradesh, Drugs Control Administration, and Hyderabad. State of the art technology having dedicated manufacturing facilities for Liquid Injections, Dry powder Injections and Readytofill Pellets ensures the highest level of process integrity and product quality.The Company started with Finished Pharmaceutical Formulations and then diversified into Readytofill Pellets, to provide customers with endtoend solution to their various pharmaceutical product needs to commercial contract drug manufacturing. It is engaged in developing New products Viz MUPS (Multiple Unit Pellet System), Sustained Release, Modified Release pellets with Innovative Drug Delivery Technologies by utilizing best and latest processing machinery. It operates a state of the art, cGMP contract manufacturing FormulationFillFinish facility, providing comprehensive pharmaceutical development and manufacturing services for drug products.
Concord Drugs Financial Highlights
For the full year FY2025–2026, revenue
reached ₹45.26 crore and profit touched at
₹0.34 crore.
Concord Drugs Share Price Today
As of 18 Sep, 2025, Concord Drugs share price is ₹68.6. The stock opened at ₹69.9 and had closed at ₹69.9 the previous day. During today’s trading session, Concord Drugs share price moved between ₹68.55 and ₹69.92, with an average price for the day of ₹69.23. Over the last 52 weeks, the stock has recorded a low of ₹26.10 and a high of ₹71.00. In terms of performance, Concord Drugs share price has increased by 101.4% over the past six months and has increased by 55.34% over the last year.
Concord Drugs SIP Return Calculator
Over the past
1 year
3 years
5 years
Total Investment of ₹65,00,000
Would have become ₹86,88,255 (+33.67%)
Daily SIP of ₹25,000 would have become ₹86,88,255 in 1 year with a gain of ₹21,88,255 (+33.67%)
Concord Drugs Fundamental
Market Cap (in crs)
68.55
Face Value
10
Turnover (in lacs)
2.36
Key Metrics
Qtr Change %
New 52W High in past week
128.5
Dividend yield 1yr %
0
Concord Drugs Key Financials
Loading chart...
Loading chart...
Loading chart...
Loading chart...
Concord Drugs Quarterly Revenue
| Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
13.61 Cr | 10.39 Cr | 10.8 Cr | 12.36 Cr | 11.69 Cr |
Concord Drugs Yearly Revenue
| Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|
45.26 Cr | 44.93 Cr | 52.09 Cr |
Concord Drugs Quarterly Net Profit/Loss
| Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
0.12 Cr | 0.04 Cr | 0.23 Cr | 0.04 Cr | 0.03 Cr |
Concord Drugs Yearly Net Profit/Loss
| Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|
0.34 Cr | 0.47 Cr | 0.99 Cr |
Concord Drugs Technical Analysis
Moving Averages Analysis
Moving Averages Analysis
68.55
Current Price
5Day EMA
68.70
10Day EMA
67.20
12Day EMA
66.50
20Day EMA
64.00
26Day EMA
62.50
50Day EMA
57.60
100Day EMA
50.60
200Day EMA
44.50
5Day SMA
69.20
10Day SMA
67.70
20Day SMA
62.40
30Day SMA
59.40
50Day SMA
59.30
100Day SMA
46.40
150Day SMA
41.80
200Day SMA
40.50
Delivery & Volume
| Period | Combined Delivery Volume | NSE+BSE Traded Volume |
|---|---|---|
Day Rs | 3440 Rs | 3440 Rs |
Week Rs | 6291 Rs | 6291 Rs |
Month Rs | 11621 Rs | 11621 Rs |
Resistance & Support
69.01
Pivot
Resistance
First Resistance
69.46
Second Resistance
70.38
Third Resistance
70.83
Support
First Support
68.09
Second support
67.64
Third Support
66.72
Relative Strength Index
69.89
Money Flow Index
86.73
MACD
4
MACD Signal
3.55
Average True Range
1.95
Average Directional Index
39.67
Rate of Change (21)
34.41
Rate of Change (125)
93.15
Concord Drugs Peer comparison
| Index Name | Market Price | Market Cap | 52W Low | 52W High | Prev. Close | 1W Return | 1M Return | 6M Return | 1Y Return | 3Y Return | Dividend Yield | PE Ratio | Industry PE | PB Ratio |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
43.48 | 70.74 | 40.4 | 87.99 | 43.46 | -0.14% | 1.99% | -0.41% | -48.07% | -16.55% | 0.00% | 25.22 | 41.16 | 3.76 | |
86.35 | 65.03 | 79 | 144 | 86.45 | 6.04% | 1.16% | -10.66% | -36.95% | 28.59% | 0.00% | 17.17 | 41.16 | 1.50 | |
80.00 | 82.04 | 60.55 | 96.77 | 81.87 | -2.38% | 5.03% | 19.23% | -13.04% | -44.37% | 0.00% | 170.21 | 92.74 | 1.44 | |
9.69 | 59.64 | 9.1 | 14.85 | 9.95 | -3.77% | -7.80% | -11.51% | -26.92% | 12.28% | 0.00% | 0.00 | 41.16 | 0.91 | |
13.59 | 68.09 | 8.16 | 31.4 | 13.92 | 17.46% | 46.76% | -37.60% | -52.18% | -63.37% | 0.00% | 19.50 | 41.16 | 0.82 | |
Accretion Pharmaceuticals Ltd. | - | 63.65 | - | - | - | - | - | - | - | - | - | - | - | - |
Concord Drugs Latest News
Concord Drugs Share Price FAQs
How to buy Concord Drugs shares?
You can easily buy Concord Drugs shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.
What is the 52-week high and low of Concord Drugs ?
The 52-week high and low of Concord Drugs share price is ₹71 and ₹26.1 as of 17/9/2025.
Please be aware that Concord Drugs stock prices are subject to continuous fluctuations due to various factors.
Invest in Concord Drugs